Stereotaxis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Stereotaxis, Inc. on May 16, 2014. The filing reports the entry into a material definitive agreement regarding a potential equity offering.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, or debt levels. The only financial figure disclosed is the maximum aggregate offering price of up to $18.0 million under the new sales agreement.
Material Changes
On May 16, 2014, the Company entered into a Controlled Equity Offering SM Sales Agreement with Cantor Fitzgerald & Co. as the sales agent. Key terms include:
- Offering Size: Up to $18.0 million in aggregate gross proceeds.
- Method: "At-the-market" offerings or other permitted methods based on Company instructions.
- Commission: Cantor Fitzgerald will receive a 3.0% commission on gross proceeds.
- Obligation: The Company is not obligated to sell any shares under this agreement.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance or management commentary on operational outlook. The transaction is subject to customary closing conditions and applicable securities laws. Sales will be made pursuant to a previously effective Form S-3 registration statement.
Investor Verification Checklist
- Verify the current market price of Stereotaxis common stock to assess potential dilution if the full $18.0 million is raised.
- Review the full text of the Sales Agreement (Exhibit 1.1) for specific price, time, or size limits the Company may impose.
- Monitor future filings to determine if and when shares are actually sold under this agreement.
- Check the Company's most recent 10-Q or 10-K for actual liquidity and cash position, as this 8-K does not provide those figures.